Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional...
Changchun High-tech Subsidiary Receives FDA Orphan Drug Designation for GenSci128, Targeting Gastric Cancer
GenSci128 Receives Orphan Drug Designation for Pancreatic Cancer Treatment
CCHT's "New Drug for Treating Male Children's Developmental Disorders" Sparks Stock Price Surge; Company Responds: Project is Still in Early Stages
"Northeast Medicine Mogul" Transforms into Innovative Pharmaceuticals
Zhitong A-share lock-up release overview | November 4
CCHT: GenSci134 injection domestic production drug registration clinical trial application approved